GlassScriptPhysician profile
Norma M Khoury
NPI 1588606263
$3,254.79
in general payments reported to CMS, 2019-2025
17 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $444 · 2021: $584 · 2022: $128 · 2023: $251 · 2024: $812 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681 · Travel and Lodging: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.70 |
| Travel and Lodging | $670.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $877.32 | 2019-2025 | |
| Boston Scientific Corporation | $817.07 | 2021-2025 | Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $382.89 | 2019-2025 | Eliquis, Camzyos |
| Biocompatibles, INC. | $262.17 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $234.72 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $207.26 | 2019-2020 | |
| Pfizer INC. | $143.65 | 2019-2021 | |
| Medtronic, INC. | $100.00 | 2023 | Venaseal |
| Amgen INC. | $60.11 | 2020-2021 | |
| Medtronic Vascular, INC. | $44.93 | 2020 | |
| Mindray Ds USA, INC. | $38.64 | 2025 | Te X, Te7 Max |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.82 | 2020 | |
| Cashflow Solutions, LLC | $15.89 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Amarin Pharma, INC. | $15.10 | 2020 | |
| Arbor Pharmaceuticals, INC. | $13.49 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norma Khoury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.